Trends in U.S and global patient enrollment from 2014 to 2022 in lung cancer clinical trials supporting marketing applications: An FDA analysis

被引：0

|

作者：

Akinboro, Oladimeji

Kumar, Vaibhav

Drezner, Nicole Lauren

Larkins, Erin A.

Pazdur, Richard

Kluetz, Paul

Singh, Harpreet

机构：

[1] US FDA, Ctr Drug Evaluat & Res, Off Oncol Dis, Off New Drugs, Silver Spring, MD USA

[2] US FDA, Oncol Ctr Excellence, Silver Spring, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1576

引用

收藏

页数：1

相关论文

共 22 条

[21] Common Arm Comparative Outcomes Analysis of Phase 3 Trials of Cisplatin plus Irinotecan Versus Cisplatin plus Etoposide in Extensive Stage Small Cell Lung Cancer Final Patient-Level Results From Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124
Lara, Primo N., Jr.
Chansky, Kari
Shibata, Taro
Fukuda, Haruhiko
Tamura, Tomohide
Crowley, John
Redman, Mary W.
Natale, Ronald
Saijo, Nagahiro
Gandara, David R.
CANCER, 2010, 116 (24) : 5710 - 5715
[22] Reply to Yongfeng Lao, Yanan Wang, and Zhilong Dong's Letter to the Editor re: Amar U. Kishan, Xiaoyan Wang, Yilun Sun, et al. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022;82:106-114
Kishan, Amar U.
Spratt, Daniel E.
EUROPEAN UROLOGY, 2022, 82 (03) : E82 - E83